Nuance Biotech

An innovative biotech company dedicated to the three major areas of pharmaceutical business operations in the Chinese market.

Launch date

2014

Employees

Market cap

Enterprise valuation

Shanghai Shanghai (HQ)

Date	Investors	Amount	Round
May 2017	Matrix Partners China	$8.0m	Series A
Jun 2018	C-Bridge Capital CBC Group	$20.0m	Series B
Mar 2019	N/A	$2.0m	Series C
Dec 2020	Matrix Partners China RTW Investments C-Bridge Capital GT Fund Konruns Pharmaceutical	$118m	Series D
Total Funding		AUD229m

Tech stackLearn more about the technologies and tools that this company uses.

ACQUISITION by Nuance Biotech Jan 2022

ACQUISITION by Nuance Biotech Jan 2022

Recent News about Nuance Biotech